Company Search:
Advanced Search
Sponsored Links
Stada Arzneimittel AG Company Snapshot
Stada Arzneimittel AG operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Stada Arzneimittel AG with three other pharmaceutical manufacturers in Europe: Hikma Pharmaceuticals PLC of the United Kingdom (2018 sales of £1.56 billion [US$2.01 billion] of which 40% was Injectable Pharmaceuticals), Ipsen SA of France (2.35 billion Euro [US$2.60 billion] of which 82% was Specialty Care), and H. Lundbeck A/S which is based in Denmark (18.12 billion Danish Kroner [US$2.68 billion] of which 100% was Pharmaceuticals).

Sales Analysis. Stada Arzneimittel AG reported sales of 2.33 billion Euro (US$2.58 billion) for the year ending December of 2018. This represents a very small increase of 0.7% versus 2017, when the company's sales were 2.31 billion Euro. Sales at Stada Arzneimittel AG have increased during each of the previous five years (and since 2013, sales have increased a total of 16%). Sales of Generics saw an increase that was more than double the company's growth rate: sales were up 1.6% in 2018, from 1.36 billion Euro to 1.38 billion Euro. Not all segments of Stada Arzneimittel AG experienced an increase in sales in 2018: sales of Branded Products fell 0.4% to 947.99 million Euro.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Stada Arzneimittel AG
  Stock Performance Chart for Stada Arzneimittel AG
  Stock Data: Recent Stock Performance:
  Current Price (11/8/2019): 86.40
(Figures in Euro)
1 Week 1.5%   13 Weeks -0.6%  
4 Weeks 3.5%   52 Weeks 6.5%  
Stada Arzneimittel AG Key Data:
  Ticker: SAZ Country: Germany
  Exchanges: FRA OTH Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2018 Sales 2,330,824,000
(Year Ending Jan 2019).
Employees: 10,416
  Currency: Euro Market Cap: 5,379,105,629
  Fiscal Yr Ends: December Shares Outstanding: 62,258,167
  Share Type: Namensaktie Closely Held Shares: 58,399,071
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.